亚洲欧美日韩成人痉挛重口_特黄三级视频不卡高清在线看_黄色欧美久久_国产成人在线观看99_日韓精品歐美國產精品亞_亚洲?V日韩?V国内怡红院_在线一级无码导航_黄色免费网站链接_中文字幕与邻居少妇性刺激_亚洲国产午夜福利网
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.11.21
海普瑞：關(guān)于修訂公司治理相關(guān)制度的公告
2023.11.21
海普瑞：關(guān)于召開(kāi)2023年第一次臨時(shí)股東大會(huì)、2023年第一次A股類別股東會(huì)議及第一次H股類...
2023.08.30
海普瑞：2023年半年度報(bào)告摘要
2023.08.30
海普瑞：獨(dú)立董事關(guān)于控股股東及其他關(guān)聯(lián)方占用公司資金、公司對(duì)外擔(dān)保情況的專項(xiàng)說(shuō)明和...
2023.08.30
海普瑞：關(guān)于控股股東承諾不減持公司股份的公告
2023.08.21
海普瑞：獨(dú)立董事關(guān)于第六屆董事會(huì)第二次會(huì)議相關(guān)事項(xiàng)的獨(dú)立意見(jiàn)
2023.08.21
海普瑞：關(guān)于變更財(cái)務(wù)總監(jiān)的公告
2023.08.21
海普瑞：第六屆董事會(huì)第二次會(huì)議決議公告
2023.07.15
海普瑞：2023年半年度業(yè)績(jī)預(yù)告
2023.07.11
海普瑞：2022年年度權(quán)益分派實(shí)施公告
第一頁(yè)
上一頁(yè)
3
4
5
6
7
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
